Author: Norman Peter
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.22, Iss.12, 2012-12, pp. : 1479-1483
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Evaluation of WO2012003387, Gilead's ASK1 inhibitors
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 4, 2012-04 ,pp. :